Molecular Diagnostic Testing for UTI
Over 150 million people each year are affected by Urinary Tract Infections (UTI). Traditional culture-based methods of testing for a UTI can take 3 days to deliver a result and are misinterpreted up to 80% of the time. This often leads to patients waiting for answers only to be misdiagnosed. Molecular diagnostic testing for UTI will produce a definitive result every time within a matter of hours and reveal if the infection is demonstrating antibiotic resistance.
Respiratory Pathogen Panel
Many deadly illnesses are caused by an upper respiratory infection. A screen test is commonly used to identify these dangerous infections. Although effective, inconsistencies in collecting enough fluid for a proper sample often yield either a false positive or a false negative result. An RPP test only requires a small amount of DNA to identify the influenza virus, in addition to several other respiratory viruses and bacteria that could cause pneumonia. The results will allow a Physician to quickly prescribe the correct treatment in a short amount of time.
Studies show that 99% of the population was born with polymorphisms, or genetic variants, that impact how they metabolize medications. What this ultimately shows is that genetics play a critical role in how a person will respond to a medicine. Pharmacogenetics testing can reduce the chances of adverse events occurring in patients taking multiple medications and increase the likelihood of positive patient outcomes.
Genetic Testing for Cancer Risk
5% to 10% of all cancers are said to be linked to genetic mutations that are passed down within a family from generation to generation. Individuals who are born with these mutations are at a higher risk of developing certain types of cancer. Molecular Diagnostic testing can identify the presence of these mutations within the genes. This information will help Physicians to design a specific treatment plan with a strict focus on disease prevention.